Published in Ann Surg Oncol on January 01, 1997
TNF-alpha augments intratumoural concentrations of doxorubicin in TNF-alpha-based isolated limb perfusion in rat sarcoma models and enhances anti-tumour effects. Br J Cancer (2000) 1.04
Dynamic contrast-enhanced MR imaging in monitoring response to isolated limb perfusion in high-grade soft tissue sarcoma: initial results. Eur Radiol (2003) 0.92
Interleukin-1beta induced vascular permeability is dependent on induction of endothelial tissue factor (TF) activity. J Transl Med (2005) 0.91
Long-term locoregional vascular morbidity after isolated limb perfusion and external-beam radiotherapy for soft tissue sarcoma of the extremity. Ann Surg Oncol (2007) 0.84
The antibody-based targeted delivery of TNF in combination with doxorubicin eradicates sarcomas in mice and confers protective immunity. Br J Cancer (2013) 0.84
Tumor necrosis factor-alpha damages tumor blood vessel integrity by targeting VE-cadherin. Ann Surg (2006) 0.81
Degree of tumour vascularity correlates with drug accumulation and tumour response upon TNF-alpha-based isolated hepatic perfusion. Br J Cancer (2003) 0.77
The pathologic response of resected synovial sarcomas to hyperthermic isolated limb perfusion with melphalan and TNF-α: a comparison with the whole group of resected soft tissue sarcomas. World J Surg Oncol (2013) 0.77
TNF-alpha and melphalan-based isolated limb perfusion: no evidence supporting the early destruction of tumour vasculature. Br J Cancer (2015) 0.75
Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N Engl J Med (2000) 6.34
Randomised controlled trial of magnetic-resonance pelvimetry in breech presentation at term. Lancet (1998) 3.25
Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial. J Clin Oncol (1996) 2.61
Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit Care Med (2000) 2.19
[Detection of the first recurrence in patients with melanoma: three quarters by the patient, one quarter during outpatient follow-up]. Ned Tijdschr Geneeskd (2008) 2.06
Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help. A SIOG surgical task force prospective study. Crit Rev Oncol Hematol (2007) 1.98
Malignant peripheral nerve sheath tumors in patients with and without neurofibromatosis. Eur J Surg Oncol (1995) 1.90
Cardiovascular morbidity in long-term survivors of metastatic testicular cancer. J Clin Oncol (2000) 1.89
The effect of surgical wounding on tumour development. Eur J Surg Oncol (1999) 1.88
Early development of the metabolic syndrome after chemotherapy for testicular cancer. Ann Oncol (2012) 1.70
Cerebellar pilocytic astrocytoma: a treatment protocol based upon analysis of 73 cases and a review of the literature. Childs Nerv Syst (1997) 1.63
Soft tissue leiomyosarcomas and malignant gastrointestinal stromal tumors: differences in clinical outcome and expression of multidrug resistance proteins. J Clin Oncol (2000) 1.62
The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis. Cancer Treat Rev (2004) 1.60
Is sentinel node biopsy beneficial in melanoma patients? A report on 200 patients with cutaneous melanoma. Eur J Surg Oncol (2002) 1.54
Aneurysmal bone cysts treated by curettage, cryotherapy and bone grafting. J Bone Joint Surg Br (1997) 1.53
Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2013) 1.52
Continuously infused carboplatin used as radiosensitizer in locally unresectable non-small-cell lung cancer: a multicenter phase III study. Ann Oncol (2004) 1.52
Continuous leakage measurement during hyperthermic isolated limb perfusion. Ann Surg Oncol (2001) 1.49
Comparison of cytogenetic abnormalities and deoxyribonucleic acid ploidy of benign, borderline malignant, and different grades of malignant soft tissue tumors. Lab Invest (1994) 1.44
Imaging of soft-tissue tumors using L-3-[iodine-123]iodo-alpha-methyl-tyrosine single photon emission computed tomography: comparison with proliferative and mitotic activity, cellularity, and vascularity. Clin Cancer Res (2000) 1.42
Late morbidity after treatment of breast cancer in relation to daily activities and quality of life: a systematic review. Eur J Surg Oncol (2003) 1.41
Predicting postoperative mortality after colorectal surgery: a novel clinical model. Colorectal Dis (2014) 1.41
Noninvasive metabolic assessment of human donor livers: prognostic value of 31P-magnetic resonance spectroscopy for early graft function. Transplantation (1997) 1.40
[Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients]. Ned Tijdschr Geneeskd (2005) 1.39
[Myositis as the first manifestation of an exacerbation of Crohn's disease]. Ned Tijdschr Geneeskd (2007) 1.39
Groin dissection in the treatment of lower-extremity melanoma. Short-term and long-term morbidity. Arch Surg (1992) 1.38
The current status of S-100B as a biomarker in melanoma. Eur J Surg Oncol (2012) 1.34
Morbidity after inguinal sentinel lymph node biopsy and completion lymph node dissection in patients with cutaneous melanoma. Eur J Surg Oncol (2006) 1.33
Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer. Ann Surg Oncol (2004) 1.31
Genetic predisposition to testicular germ-cell tumours. Lancet Oncol (2004) 1.28
Epiphyseal fractures in children treated for osteosarcoma of the femur with chemotherapy, tumourresection, and endoprosthesis: report of four fractures in two children. J Surg Oncol (1984) 1.28
Prevalence of paraneoplastic hyperthyroidism in patients with metastatic non-seminomatous germ-cell tumors. Ann Oncol (2009) 1.25
Permanent muscle weakness in familial hypokalaemic periodic paralysis. Clinical, radiological and pathological aspects. Brain (1990) 1.24
Limb salvage surgery for primary bone sarcoma of the lower extremities: long-term consequences of endoprosthetic reconstructions. Ann Surg Oncol (1998) 1.24
Patient motivation and informed consent in a phase I study of an anticancer agent. Eur J Cancer Clin Oncol (1984) 1.23
Cancer, fertility and pregnancy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2010) 1.23
Function and complications after ablative and limb-salvage therapy in lower extremity sarcoma of bone. J Surg Oncol (2000) 1.22
Wound-induced tumor progression: a probable role in recurrence after tumor resection. Arch Surg (1998) 1.22
Malignant parotid tumors: clinical use of MR imaging and histologic correlation. Radiology (1992) 1.21
Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I or II breast cancer. Eur J Surg Oncol (2006) 1.21
Frozen section investigation of the sentinel node in malignant melanoma and breast cancer. Ann Surg Oncol (2001) 1.19
Detection of unknown occult primary tumors using positron emission tomography. Cancer (1998) 1.18
Aggressive fibromatosis (non-familial desmoid tumour): therapeutic problems and the role of adjuvant radiotherapy. Br J Surg (1995) 1.17
Familial testicular cancer in a single-centre population. Eur J Cancer (1999) 1.17
Primitive neuroectodermal tumors of the central nervous system. Patterns of expression of neuroendocrine markers, and all classes of intermediate filament proteins. Lab Invest (1990) 1.15
Long-term prognosis of primary retroperitoneal soft tissue sarcoma. Eur J Surg Oncol (2006) 1.15
External and internal hemipelvectomy for sarcomas of the pelvic girdle: consequences of limb-salvage treatment. Eur J Surg Oncol (1997) 1.15
Slight cognitive impairment and magnetic resonance imaging abnormalities but normal school levels in children treated for acute lymphoblastic leukemia with chemotherapy only. J Pediatr (2001) 1.14
Locoregional recurrence of retroperitoneal soft tissue sarcoma: second chance of cure for selected patients. Eur J Surg Oncol (2001) 1.13
Sexual functioning after treatment for testicular cancer--review and meta-analysis of 36 empirical studies between 1975-2000. Arch Sex Behav (2001) 1.13
Fluorine-18-fluorodeoxyglucose PET imaging of soft-tissue sarcoma. J Nucl Med (1996) 1.11
Chromosomal analysis and the classification of soft tissue sarcomas. Lab Invest (1989) 1.10
Analysis of proliferation and apoptosis in brain gliomas: prognostic and clinical value. J Neurooncol (1999) 1.10
Some effects of combination chemotherapy with cis-platinum on renal function in patients with nonseminomatous testicular carcinoma. Cancer (1983) 1.09
Mesenchymal and muscle-specific intermediate filaments (vimentin and desmin) in relation to differentiation in childhood rhabdomyosarcomas. Hum Pathol (1985) 1.08
Cytologic "differentiation" in childhood rhabdomyosarcomas following polychemotherapy. Hum Pathol (1984) 1.07
Rearrangements involving 12p12 in two cases of cardiac myxoma. Cancer Genet Cytogenet (1995) 1.06
The significance of the doctor-patient relationship in coping with cancer. Soc Sci Med (1984) 1.05
Pre-operative assessment of cancer in the elderly (PACE): a comprehensive assessment of underlying characteristics of elderly cancer patients prior to elective surgery. Surg Oncol (2006) 1.04
Extensive mutation scanning of RET in sporadic medullary thyroid carcinoma and of RET and VHL in sporadic pheochromocytoma reveals involvement of these genes in only a minority of cases. J Clin Endocrinol Metab (1996) 1.04
Invasive fibrous thyroiditis (Riedel's struma): a manifestation of multifocal fibrosclerosis? A case report with review of the literature. Q J Med (1989) 1.04
Soft tissue sarcoma--compliance with guidelines. Cancer (2001) 1.04
Asymptomatic pseudotumours after metal-on-metal hip resurfacing show little change within one year. Bone Joint J (2013) 1.03
The effect of chemotherapy on the growing skeleton. Cancer Treat Rev (2000) 1.03
High frequency of TP53 mutations in juvenile pilocytic astrocytomas indicates role of TP53 in the development of these tumors. Brain Pathol (1999) 1.02
Magnetic resonance imaging of the brain and neuropsychological evaluation in children treated for acute lymphoblastic leukemia at a young age. Am J Pediatr Hematol Oncol (1993) 1.01
Osteosarcoma of the pelvis--oncological results of 40 patients registered by The Netherlands Committee on Bone Tumours. Eur J Surg Oncol (2000) 1.01
Dermatofibrosarcoma protuberans: recurrence is related to the adequacy of surgical margins. Eur J Surg Oncol (2009) 1.01
Phase II study of bleomycin, actinomycin D, DTIC and vindesine in disseminated malignant melanoma. Eur J Cancer Clin Oncol (1986) 1.01
Therapeutic groin dissection for melanoma: risk factors for short term morbidity. Eur J Surg Oncol (2008) 1.01
Cytogenetic analysis of adamantinoma of long bones: further indications for a common histogenesis with osteofibrous dysplasia. Cancer Genet Cytogenet (1997) 1.00
Left atrial herniation through a partial pericardial defect: a rare cause of syncope. Pacing Clin Electrophysiol (1989) 1.00
Microalbuminuria, decreased fibrinolysis, and inflammation as early signs of atherosclerosis in long-term survivors of disseminated testicular cancer. Eur J Cancer (2004) 0.99
Clinico-pathological data and prognostic factors in completely resected AJCC stage I-III liposarcomas. Ann Surg Oncol (2000) 0.99
Fluorodeoxyglucose-positron emission tomography and sentinel lymph node biopsy in staging primary cutaneous melanoma. Eur J Surg Oncol (2003) 0.98
Current treatment for colorectal cancer metastatic to the liver. Eur J Surg Oncol (1999) 0.98